Morgan Stanley’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13M Buy
1,001,723
+595,337
+146% +$7.74M ﹤0.01% 3200
2025
Q1
$10.3M Buy
406,386
+14,187
+4% +$358K ﹤0.01% 3318
2024
Q4
$13.5M Sell
392,199
-94,701
-19% -$3.26M ﹤0.01% 3124
2024
Q3
$24.1M Sell
486,900
-630,358
-56% -$31.2M ﹤0.01% 2614
2024
Q2
$67.2M Sell
1,117,258
-8,393
-0.7% -$505K 0.01% 1475
2024
Q1
$58.1M Sell
1,125,651
-1,020,473
-48% -$52.6M ﹤0.01% 1617
2023
Q4
$86.5M Buy
2,146,124
+934,720
+77% +$37.7M ﹤0.01% 1877
2023
Q3
$33.8M Sell
1,211,404
-295,671
-20% -$8.25M ﹤0.01% 1925
2023
Q2
$43.4M Buy
1,507,075
+1,451,598
+2,617% +$41.8M ﹤0.01% 1698
2023
Q1
$925K Buy
55,477
+32,008
+136% +$534K ﹤0.01% 4905
2022
Q4
$297K Sell
23,469
-3,735
-14% -$47.3K ﹤0.01% 5496
2022
Q3
$326K Buy
27,204
+17,708
+186% +$212K ﹤0.01% 5487
2022
Q2
$134K Buy
9,496
+5,964
+169% +$84.2K ﹤0.01% 6116
2022
Q1
$44K Buy
3,532
+1,515
+75% +$18.9K ﹤0.01% 6769
2021
Q4
$23K Buy
2,017
+478
+31% +$5.45K ﹤0.01% 7171
2021
Q3
$19K Buy
+1,539
New +$19K ﹤0.01% 7119